Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levosimendan and Inhaled Nitric Oxide for Resuscitating the Microcirculation in Septic Shock. A Randomized Controlled Trial

NCT00800306 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT00800306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00800306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levosimendan and Inhaled Nitric Oxide for Resuscitating the Microcirculation in Septic Shock. A Randomized Controlled Trial
Lead sponsor
University of Roma La Sapienza
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
April 30, 2009
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock